<?xml version="1.0" encoding="UTF-8"?>
<ref id="B18-ijms-21-03099">
 <label>18.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Shi</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Hao</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Zou</surname>
    <given-names>Q.</given-names>
   </name>
  </person-group>
  <article-title>Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening</article-title>
  <source>bioRxiv</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1101/2020.01.28.922922</pub-id>
 </element-citation>
</ref>
